Omeros (OMER) Gains from Equity Investments (2022 - 2025)

Omeros (OMER) reported Gains from Equity Investments of -$3.7 million for Q4 2025, down 536.92% on a YoY basis from $852781.7 in Q4 2024, and down 127.8% sequentially from $13.4 million in Q3 2025.

Omeros (OMER) Gains from Equity Investments (2022 - 2025) Analysis & Trends

Omeros (OMER) has 4 years of Gains from Equity Investments data on file, last reported at -$3.7 million in Q4 2025.

  • For the quarter ending Q4 2025, Gains from Equity Investments fell 536.92% year-over-year to -$3.7 million; the trailing twelve-month figure through Dec 2025 stood at $12.7 million (up 258.83% YoY), and the FY2025 full-year result was $12.7 million, up 258.83% from the prior year.
  • Gains from Equity Investments retreated to -$3.7 million in Q4 2025, from $13.4 million in the prior quarter.
  • In the past five years, Gains from Equity Investments ranged from a high of $26.2 million in Q4 2022 to a low of -$29.7 million in Q4 2023.
  • A 4-year average of -$792692.3 and a median of -$2.3 million in 2024 frame the typical range for Gains from Equity Investments.
  • Peak annual rise in Gains from Equity Investments reached 1933.38% in 2025, while the deepest fall reached 536.92% in 2025.
  • Tracing OMER's Gains from Equity Investments over 4 years: stood at $26.2 million in 2022, then slumped by 213.41% to -$29.7 million in 2023, then soared by 98.03% to -$585000.0 in 2024, then sank by 536.92% to -$3.7 million in 2025.
  • Business Quant data shows OMER's Gains from Equity Investments at -$3.7 million in Q4 2025, $13.4 million in Q3 2025, and $3.1 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,801.52 Bn 66,801.23 Bn -
2 Nanobiotix 1,935.05 Bn 1,934.98 Bn -
3 Akari Therapeutics 1,021.31 Bn 1,021.31 Bn -
4 BeOne Medicines 467.89 Bn 463.10 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.95 Bn 115.70 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.19 Bn 61.44 Bn 3.31 Bn
7 Belite Bio 63.46 Bn 63.46 Bn -
8 Argenx Se 55.64 Bn 50.45 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.67 Bn 34.66 Bn 959.66 Mn
10 Omeros 781.02 Mn 781.02 Mn 9.31 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -3.73 Mn
Dec 31, 2025 -3.73 Mn
Sep 30, 2025 13.40 Mn
Sep 30, 2025 13.40 Mn
Jun 30, 2025 3.15 Mn
Jun 30, 2025 3.15 Mn
Mar 31, 2025 -166,000.00
Mar 31, 2025 -166,000.00
Dec 31, 2024 -585,000.00
Dec 31, 2024 -585,000.00
Sep 30, 2024 -731,000.00
Sep 30, 2024 -731,000.00
Jun 30, 2024 -4.31 Mn
Jun 30, 2024 -4.31 Mn
Mar 31, 2024 -2.34 Mn
Mar 31, 2024 -2.34 Mn
Dec 31, 2023 -29.68 Mn
Dec 31, 2023 -29.68 Mn
Sep 30, 2023 -3.73 Mn
Sep 30, 2023 -3.73 Mn